scholarly journals The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial

2012 ◽  
Vol 4 (1) ◽  
Author(s):  
Robert Frederich ◽  
Robert McNeill ◽  
Niklas Berglind ◽  
Douglas Fleming ◽  
Roland Chen
Sign in / Sign up

Export Citation Format

Share Document